Explore a multicenter real-world analysis highlighting the clinical activity of combined MET and EGFR inhibition in NSCLC after EGFR inhibitor therapy, suggesting that true MET amplification, rather than polysomy, is associated with clinical benefit. bit.ly/4di4pHT

Online First: Adaptive #radiotherapy (up to 74 Gy) or standard radiotherapy (66 Gy) for patients with stage III non-small-cell #lungcancer, according to [18F]FDG-PET uptake (RTEP7–IFCT-1402): a multicentre, randomised, controlled, phase 2 trial thelancet.com/journals/lanon…

#WCLCESMO24Update BTOG webinar - our experts will bring you the relevant presentations from these two landmark conferences, with a focus on the research that might change practice in the UK. Led by Tom Newsom-Davis Tuesday 1st October, 2024 | 18.00-19.30 CPD applied for.

Randomized Controlled Trial of a Nurse-Led Brief Behavioral Intervention for Dyspnea in Patients With Advanced #LungCancer: brnw.ch/21wLPpr #lcsm

🔥#WCLC24 abstracts 💉Shifting the Bar in the Front Line IO Setting ✅Chairs: Tom Newsom-Davis Dr. Nandini Menon 🎙️Dr. Ana Baramidze 🎯Cemiplimab for 1st Line Advanced NSCLC Pts with PD-L1 ≥50%: 5-y Outcomes of EMPOWER-Lung 1 #LCSM IASLC OncoAlert cattendee.abstractsonline.com/meeting/20598

Less than 4 months to our #Mesothelioma Essential Update with Mesothelioma UK #mesoupdate24 - put a note in your calendar. Programme available btog.org/mesothelioma-e…

Can Alternative Criteria Help Identify Patients Who May Benefit From Lung Cancer Screening? ascopost.com/news/august-20… #LCSM #lungcancer #screening

AI May Help Uncover Relationship Between Radiation Therapy for NSCLC and Cardiac Arrhythmia ascopost.com/news/august-20… #LCSM #lungcancer #radonc #AI #arrhythmia #JACCCardioOnc

A lung cancer patient at UCLH is the first in the UK to receive a novel cancer vaccine as part of a clinical trial. The vaccine made by BioNTech SE is designed to prime the immune system to recognise and fight cancer cells. buff.ly/3YWvqwu

The Lung Team at the Christie is currently recruiting in studies for patients with stage 4 ROS1+ NSCLC who have received at least one previous line of treatment. If interested, please email [email protected] BTOG The ROS1ders, Inc.

Look out for the @BTOGorg / Mesothelioma UK Mesothelioma Essential Update in London on 9 December 2024, led by Riyaz Shah for BTOG and Liz Darlison for Mesothelioma UK. Find out more and register at btog.org/mesothelioma-e… #mesothelioma #mesoupdate24

4 weeks to #WCLCESMO24Update BTOG webinar - our experts will bring you the relevant presentations from these two landmark conferences, with a focus on the research that might change practice in the UK. Led by Tom Newsom-Davis 01-10-24 18.00-19.30 btog.org/wclc-esmo-2024…

We are pleased to announce that our journal now accepts *Trial in Progress (TiP) papers*, including ongoing phase II and III trials registered with NCI's Clinical Trials Reporting Program. All submission guidelines are available here 🔗sciencedirect.com/journal/lung-c…

Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor-Resistant, EGFR-Mutant Metastatic Nonsquamous Non-Small Cell #LungCancer: brnw.ch/21wMj2H #lcsm #NSCLC

Tune in to hear more from Dr. Martin Reck (Martin Reck), as he presents the 5yr update of CheckMate 9LA & exploratory analysis of efficacy in pts who discontinued treatment due to TRAEs in pts w/ metastatic non-small #LungCancer. #lcsm onclive.com/view/five-year…

Compassion fatigue session #WCLC24 Scary fact of the day ➡️ Over 50% of patients are being treated by a burned-out oncologist. What can we do to address this? IASLC The Royal College of Radiologists BTOG

His conclusions

3 months from today to our Mesothelioma Essential Update with Mesothelioma UK #mesoupdate24. Registration now open for HCPs btog.org/mesothelioma-e…

Couldn't have said it better ourselves!

#WCLCESMO24Update BTOG webinar - our experts will bring you the relevant presentations from these two landmark conferences, with a focus on the research that might change practice in the UK.01-10-24 18.00-19.30 btog.org/wclc-esmo-2024…